Doing Business At the intersection of science, law, and policy

Your global business partners for addressing legal, scientific, and regulatory challenges.

Competitive Advantage

Bergeson & Campbell, P.C. (B&C®), is a Washington D.C. law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product approval and regulation, product defense, and associated business issues. 

We help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products throughout the world. Our Mission is to get them to market faster and more efficiently than the competition.

More About Us
Lab and planting seeds

Knowledge & Insights

  September 12, 2025
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  December 16, 2025
Memoranda
Cracks in the Enamel: The Ascendance of Federal and State Action to Restrict Fluoride Use 

Fluoride, well-known for its anticavity properties, has seen a growing number of state and federal initiatives seeking to limit or prohibit various...

  December 15, 2025
Monthly Federal Developments Memorandum
Recent Federal Developments for December 2025

Bergeson & Campbell, P.C. extends its best wishes to our clients and many friends. We wish you and your family a safe and healthy New Year. As we...

  December 8, 2025
Memoranda
EPA Begins Public Comment Period on Updated Draft Risk Calculation Memorandum for Formaldehyde

On December 3, 2025, the U.S. Environmental Protection Agency (EPA) announced the availability of and solicited public comment on an Updated Draft...

  December 5, 2025
Memoranda
European Union Deforestation Regulation Faces Likely Delay

The European Union Deforestation Regulation (EUDR) appears to be headed for yet another full-year delay following growing political pressure, concerns...

  December 2, 2025
Memoranda
White House OSTP Issues RFI Regarding “Accelerating the American Scientific Enterprise”

On Thanksgiving Eve, November 26, 2025, the White House Office of Science and Technology Policy (OSTP) requested input from interested parties on...

  November 25, 2025
Memoranda
EPA Publishes Default Values Used in New Chemical Risk Assessments under TSCA

On November 24, 2025, the U.S. Environmental Protection Agency (EPA) released the key default values that it uses in its risk assessments of new...

Seminars & Webinars

  October 29, 2025
Seminars & Webinars
TSCA Developments 2026, February 5, 2026, via webinar

Chemical Watch presents TSCA Developments 2026, covering TSCA and its business-critical implications, including risk evaluation and management rules,...

  November 6, 2025
Seminars & Webinars
Environmental Law 2026, February 19-20, 2026, Washington, D.C. and via webcast

ALI CLE presents “Environmental Law 2026,” a two-day program on the latest developments across every major area of environmental law—from air,...

  December 9, 2025
Seminars & Webinars
GlobalChem, February 22-24, 2026, Washington, D.C.

GlobalChem, presented by the American Chemistry Council, brings together industry professionals to review recent developments in global chemicals...

We partner with our clients to help them get products quickly and efficiently to market–in any country or locale–and keep them there.

Our Firms

our people

Government affairs experts, including five high-level EPA alumni. Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, and five Ph.D.'s. Trusted, respected, and highly rated attorneys who have worked on some of the toughest regulatory and legal issues of our time.

B&C, Acta, and BCCM provide a full range of global support for the commercialisation of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.

Hexagons image collage

A true business partner with clients, B&C delivers vital expertise in business strategy development, compliance planning, product defense, policy advocacy, and related activities.